Medizinische Klinik A

Radiomics of Tumor Heterogeneity in 18F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer.
Ventura D, Schindler P, Masthoff M, Görlich D, Dittmann M, Heindel W, Schäfers M, Lenz G, Wardelmann E, Mohr M, Kies P, Bleckmann A, Roll W, Evers G.
Cancers (Basel). 2023 Apr 14;15(8):2297. doi: 10.3390/cancers15082297. PMID: 37190228; PMCID: PMC10136892.

Risk Factors in HIV-1 Positive Patients on the Intensive Care Unit: A Single Center Experience from a Tertiary Care Hospital.
Schulze AB, Mohr M, Sackarnd J, Schmidt LH, Tepasse PR, Rosenow F, Evers G.
Viruses. 2023 May 13;15(5):1164. doi: 10.3390/v15051164. PMID: 37243250; PMCID: PMC10224348.

High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts.
Schulze AB, Wenge DV, Evers G, Heitkötter B, Bleckmann A, Schmidt LH, Mohr M, Hartmann W, Arteaga MF, Mikesch JH.
Transl Lung Cancer Res. 2023 Apr 28;12(4):727-741. doi: 10.21037/tlcr-22-714. Epub 2023 Mar 23. PMID: 37197633; PMCID: PMC10183409.

Liquid Biopsies in Lung Cancer.
Kemper M, Krekeler C, Menck K, Lenz G, Evers G, Schulze AB, Bleckmann A.
Cancers (Basel). 2023 Feb 23;15(5):1430. doi: 10.3390/cancers15051430. PMID: 36900221; PMCID: PMC10000706.

Respiratory motion correction in F-18-FDG PET/CT impacts lymph node assessment in lung cancer patients.
Noto B, Roll W, Zinken L, Rischen R, Kerschke L, Evers G, Heindel W, Schäfers M, Büther F.
EJNMMI Res. 2022 Sep 15;12(1):61. doi: 10.1186/s13550-022-00926-7.
PMID: 36107357; PMCID: PMC9478021.

Persistent capillary rarefication in long COVID syndrome.
Osiaevi I, Schulze AB, Evers G, Harmening K, Vink H, Kümpers P, Mohr M, Rovas A.
Angiogenesis. 2023 Feb;26(1):53-61. doi: 10.1007/s10456-022-09850-9. Epub 2022 Aug 11.
PMID: 35951203; PMCID: PMC9366128.

High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma.
Schulze AB, Kuntze A, Schmidt LH, Mohr M, Marra A, Hillejan L, Schulz C, Görlich D, Hartmann W, Bleckmann A, Evers G.
Cancers (Basel). 2022 Mar 9;14(6):1395. doi: 10.3390/cancers14061395.
PMID: 35326547; PMCID: PMC8946072.

Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience.
Evers G, Schulze AB, Osiaevi I, Harmening K, Vollenberg R, Wiewrodt R, Pistulli R, Boentert M, Tepasse PR, Sindermann JR, Yilmaz A, Mohr M.
Can Respir J. 2022 Mar 1;2022:2466789. doi: 10.1155/2022/2466789. eCollection 2022.
PMID: 35242250 Free PMC article.

Central airway obstruction treatment with self-expanding covered Y-carina nitinol stents: A single center retrospective analysis.
Schulze AB, Evers G, Tenk FS, Schliemann C, Schmidt LH, Görlich D, Mohr M.
Thorac Cancer. 2022 Feb 24. doi: 10.1111/1759-7714.14359. Online ahead of print.
PMID: 35199949

Response to the Letter: Sleep-Disordered Breathing in Precapillary Pulmonary Hypertension: Is the Prevalence So High? Reference Article: Sleep-Disordered Breathing and Nocturnal Hypoxemia in Precapillary Pulmonary Hypertension: Prevalence, Pathophysiological Determinants and Clinical Consequences by Zheng Z et al.
Spiesshoefer J, Herkenrath SD, Harre K, Kahles F, Florian AR, Mohr M, Naughton M, Randerath WJ, Emdin M, Passino C, Regmi B, Dreher M, Boentert M, Giannoni A.
Respiration. 2021 Dec 17:1-3. doi: 10.1159/000521208. Online ahead of print.
PMID: 34923494 No abstract available.

Effect of Training on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction.
Schulze AB, Evers G, Mohr M.
JAMA. 2021 Aug 24;326(8):771-772. doi: 10.1001/jama.2021.10049.
PMID: 34427610 No abstract available.

A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients.
Drakos S, Chatzantonis G, Bietenbeck M, Evers G, Schulze AB, Mohr M, Fonfara H, Meier C, Yilmaz A.
Sci Rep. 2021 Aug 2;11(1):15667. doi: 10.1038/s41598-021-95277-z.
PMID: 34341436 Free PMC article. Clinical Trial.

1. Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.

Sidell DR, Balakrishnan K, Best SR, Zur K, Buckingham J, De Alarcon A, Baroody FM, Bock JM, Boss EF, Bower CM, Campisi P, Chen SF, Clarke JM, Clarke KD, Cocciaglia A, Cotton RT, Cuestas G, Davis KL, DeFago VH, Dikkers FG, Dossans I, Florez W, Fox E, Friedman AD, Grant N, Hamdi O, Hogikyan ND, Johnson K, Johnson LB, Johnson RF, Kelly P, Klein AM, Lawlor CM, Leboulanger N, Levy AG, Lam D, Licameli GR, Long S, Lott DG, Manrique D, McMurray JS, Meister KD, Messner AH, Mohr M, Mudd P, Mortelliti AJ, Novakovic D, Ongkasuwan J, Peer S, Piersiala K, Prager JD, Pransky SM, Preciado D, Raynor T, Rinkel RNPM, Rodriguez H, Rodríguez VP, Russell J, Scatolini ML, Scheffler P, Smith DF, Smith LP, Smith ME, Smith RJH, Sorom A, Steinberg A, Stith JA, Thompson D, Thompson JW, Varela P, White DR, Wineland AM, Yang CJ, Zdanski CJ, Derkay CS.

Laryngoscope. 2021 Jan 6. doi: 10.1002/lary.29343. Online ahead of print.

PMID: 33405268

2. Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.

Evers G, Schliemann C, Beule A, Schmidt LH, Schulze AB, Kessler C, Hoffmann TK, Wiewrodt R, Groll AH, Bleckmann A, Rudack C, Berdel WE, Mohr M.

Laryngoscope. 2020 Dec 31. doi: 10.1002/lary.29351. Online ahead of print.

PMID: 33382105

3. Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience.

Evers G, Schulze AB, Thrull M, Hering JP, Schülke C, Wiewrodt R, Wittkowski H, Schmidt LH, Mohr M.

Can Respir J. 2020 May 27;2020:4019608. doi: 10.1155/2020/4019608. eCollection 2020.

PMID: 32566054 Free PMC article.

4. Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer.

Schulze AB, Evers G, Görlich D, Mohr M, Marra A, Hillejan L, Rehkämper J, Schmidt LH, Heitkötter B.

J Thorac Dis. 2020 May;12(5):1824-1842. doi: 10.21037/jtd-19-3414a.

PMID: 32642087 Free PMC article.

5. Respiratory Muscle and Lung Function in Lung Allograft Recipients: Association with Exercise Intolerance.

Spiesshoefer J, Henke C, Kabitz HJ, Nofer JR, Mohr M, Evers G, Strecker JK, Brix T, Randerath WJ, Herkenrath S, Schmidt LH, Boentert M.

Respiration. 2020;99(5):398-408. doi: 10.1159/000507264. Epub 2020 May 13.

PMID: 32403109

6. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.

Schulze AB, Schmidt LH, Heitkötter B, Huss S, Mohr M, Marra A, Hillejan L, Görlich D, Barth PJ, Rehkämper J, Evers G.

Thorac Cancer. 2020 Jan;11(1):120-129. doi: 10.1111/1759-7714.13248. Epub 2019 Nov 24.

PMID: 31760702 Free PMC article.

7. Blood clot removal by cryoextraction in critically ill patients with pulmonary hemorrhage.

Schmidt LH, Schulze AB, Goerlich D, Schliemann C, Kessler T, Rottmann V, den Toom D, Rosenow F, Sackarnd J, Evers G, Mohr M.

J Thorac Dis. 2019 Oct;11(10):4319-4327. doi: 10.21037/jtd.2019.09.46.

PMID: 31737317 Free PMC article.

8. Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function.

Spiesshoefer J, Herkenrath S, Mohr M, Randerath W, Tuleta I, Diller GP, Emdin M, Young P, Henke C, Florian AR, Yilmaz A, Boentert M, Giannoni A.

Biosci Rep. 2019 Sep 3;39(9):BSR20190392. doi: 10.1042/BSR20190392. Print 2019 Sep 30.

PMID: 31427479 Free PMC article.

9. The German National Registry of Primary Immunodeficiencies (2012-2017).

El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, Speckmann C, Rusch S, Scheible R, Warnatz K, Atschekzei F, Beider R, Ernst D, Gerschmann S, Jablonka A, Mielke G, Schmidt RE, Schürmann G, Sogkas G, Baumann UH, Klemann C, Viemann D, von Bernuth H, Krüger R, Hanitsch LG, Scheibenbogen CM, Wittke K, Albert MH, Eichinger A, Hauck F, Klein C, Rack-Hoch A, Sollinger FM, Avila A, Borte M, Borte S, Fasshauer M, Hauenherm A, Kellner N, Müller AH, Ülzen A, Bader P, Bakhtiar S, Lee JY, Heß U, Schubert R, Wölke S, Zielen S, Ghosh S, Laws HJ, Neubert J, Oommen PT, Hönig M, Schulz A, Steinmann S, Schwarz K, Dückers G, Lamers B, Langemeyer V, Niehues T, Shai S, Graf D, Müglich C, Schmalzing MT, Schwaneck EC, Tony HP, Dirks J, Haase G, Liese JG, Morbach H, Foell D, Hellige A, Wittkowski H, Masjosthusmann K, Mohr M, Geberzahn L, Hedrich CM, Müller C, Rösen-Wolff A, Roesler J, Zimmermann A, Behrends U, Rieber N, Schauer U, Handgretinger R, Holzer U, Henes J, Kanz L, Boesecke C, Rockstroh JK, Schwarze-Zander C, Wasmuth JC, Dilloo D, Hülsmann B, Schönberger S, Schreiber S, Zeuner R, Ankermann T, von Bismarck P, Huppertz HI, Kaiser-Labusch P, Greil J, Jakoby D, Kulozik AE, Metzler M, Naumann-Bartsch N, Sobik B, Graf N, Heine S, Kobbe R, Lehmberg K, Müller I, Herrmann F, Horneff G, Klein A, Peitz J, Schmidt N, Bielack S, Groß-Wieltsch U, Classen CF, Klasen J, Deutz P, Kamitz D, Lassay L, Tenbrock K, Wagner N, Bernbeck B, Brummel B, Lara-Villacanas E, Münstermann E, Schneider DT, Tietsch N, Westkemper M, Weiß M, Kramm C, Kühnle I, Kullmann S, Girschick H, Specker C, Vinnemeier-Laubenthal E, Haenicke H, Schulz C, Schweigerer L, Müller TG, Stiefel M, Belohradsky BH, Soetedjo V, Kindle G, Grimbacher B.

Front Immunol. 2019 Jul 19;10:1272. doi: 10.3389/fimmu.2019.01272. eCollection 2019.

PMID: 31379802 Free PMC article.

10. Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.

Schulze AB, Evers G, Kerkhoff A, Mohr M, Schliemann C, Berdel WE, Schmidt LH.

Cancers (Basel). 2019 May 17;11(5):690. doi: 10.3390/cancers11050690.

PMID: 31108964 Free PMC article. Review.

11. Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experience.

Schmidt LH, Huss S, Schuelke C, Schulze A, Evers G, Schliemann C, Hansmeier A, Schilling B, Lauterbach B, Barth P, Wiebe K, Goerlich D, Berdel WE, Puehse G, Mohr M.

Urol Oncol. 2019 Aug;37(8):531.e17-531.e25. doi: 10.1016/j.urolonc.2019.03.010. Epub 2019 Apr 30.

PMID: 31053525

12. [Primary Immunodeficiency: Primary Antibody Disorders in Respiratory Medicine].

Evers G, Thrull M, Wittkowski H, Schmidt LH, Mohr M.

Pneumologie. 2019 Feb;73(2):94-107. doi: 10.1055/s-0043-108085. Epub 2019 Feb 13.

PMID: 30759496 German.

13. Cyclophosphamide pulse therapy as treatment for severe interstitial lung diseases.

Schulze AB, Evers G, Kümmel A, Rosenow F, Sackarnd J, Hering JP, Schülke C, Engelbertz JA, Görlich D, Barth PJ, Lenz G, Becker H, Mohr M, Schmidt LH.

Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(2):157-166. doi: 10.36141/svdld.v36i2.7636. Epub 2019 May 1.

PMID: 32476949 Free PMC article.

14. Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure.

Spiesshoefer J, Becker S, Tuleta I, Mohr M, Diller GP, Emdin M, Florian AR, Yilmaz A, Boentert M, Giannoni A.

Respiration. 2019;98(6):482-494. doi: 10.1159/000502155. Epub 2019 Aug 28.

PMID: 31461730

15. Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer.

Schmidt LH, Heitkötter B, Schulze AB, Schliemann C, Steinestel K, Trautmann M, Marra A, Hillejan L, Mohr M, Evers G, Wardelmann E, Rahbar K, Görlich D, Lenz G, Berdel WE, Hartmann W, Wiewrodt R, Huss S.

PLoS One. 2017 Oct 27;12(10):e0186280. doi: 10.1371/journal.pone.0186280. eCollection 2017.

PMID: 29077706 Free PMC article.

16. Individualisierte Therapie des metastasierten Lungenkarzinoms.

Evers G, Mohr M, Kerkhoff A, Lenz G, Wiewrodt R, Schmidt LH.

Dtsch Med Wochenschr. 2017 Oct;142(20):1531-1534. doi: 10.1055/s-0043-103471. Epub 2017 Oct 10.

PMID: 29017211 German.

17. CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.

Schmidt LH, Stucke-Ring J, Brand C, Schliemann C, Harrach S, Muley T, Herpel E, Kessler T, Mohr M, Görlich D, Kreuter M, Lenz G, Wardelmann E, Thomas M, Berdel WE, Schwöppe C, Hartmann W.

Lung Cancer. 2017 Nov;113:121-127. doi: 10.1016/j.lungcan.2017.09.013. Epub 2017 Sep 22.

PMID: 29110838

18. Temporary Tracheal Stenting After Pulmonary Artery Sling Repair in a Newborn.

Lueck S, Mohr M, Werner C, Schmidt C, Malec E, Januszewska K.

World J Pediatr Congenit Heart Surg. 2020 Jul;11(4):NP69-NP71. doi: 10.1177/2150135117713740. Epub 2017 Sep 21.

PMID: 28933231

19. Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.

Schmidt LH, Brand C, Stucke-Ring J, Schliemann C, Kessler T, Harrach S, Mohr M, Görlich D, Marra A, Hillejan L, Müller-Tidow C, Lenz G, Wardelmann E, Wiewrodt R, Berdel WE, Schwöppe C, Hartmann W.

PLoS One. 2017 Aug 9;12(8):e0183201. doi: 10.1371/journal.pone.0183201. eCollection 2017.

PMID: 28793330 Free PMC article.

20. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey.

Best SR, Mohr M, Zur KB.

Laryngoscope. 2017 Oct;127(10):2225-2229. doi: 10.1002/lary.26662. Epub 2017 Jun 28.

PMID: 28657692 Free PMC article.

21. Potential therapeutic impact of CD13 expression in non-small cell lung cancer.

Schmidt LH, Brand C, Stucke-Ring J, Schliemann C, Kessler T, Harrach S, Mohr M, Görlich D, Marra A, Hillejan L, Müller-Tidow C, Lenz G, Wardelmann E, Wiewrodt R, Berdel WE, Schwöppe C, Hartmann W.

PLoS One. 2017 Jun 12;12(6):e0177146. doi: 10.1371/journal.pone.0177146. eCollection 2017.

PMID: 28604784 Free PMC article.

22. Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literature.

Schulze AB, Heptner B, Kessler T, Baumgarten B, Stoica V, Mohr M, Wiewrodt R, Warneke VS, Hartmann W, Wüllenweber J, Schülke C, Schäfers M, Wilmes D, Becker K, Schmidt LH, Groll AH, Berdel WE.

Eur J Haematol. 2017 Jul;99(1):91-100. doi: 10.1111/ejh.12886. Epub 2017 May 11.

PMID: 28349614 Review.

23. Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung.

Schulze AB, Schmidt LH, Baie L, Heitkötter B, Kuemmel A, Mohr M, Buhl R, Hillmann H, Geißler G, Kelsch R, Görlich D, Berdel WE, Hartmann W, Wiewrodt R.

Clin Respir J. 2018 Mar;12(3):1106-1117. doi: 10.1111/crj.12638. Epub 2017 Apr 26.

PMID: 28398662

24. Management of destructive Candida albicans spondylodiscitis of the cervical spine: a systematic analysis of literature illustrated by an unusual case.

Stolberg-Stolberg J, Horn D, Roßlenbroich S, Riesenbeck O, Kampmeier S, Mohr M, Raschke MJ, Hartensuer R.

Eur Spine J. 2017 Apr;26(4):1009-1018. doi: 10.1007/s00586-016-4827-3. Epub 2016 Nov 5.

PMID: 27817136 Review.

25. Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision.

Schmidt LH, Vietmeier B, Kaleschke G, Schülke C, Görlich D, Schliemann C, Kessler T, Schulze AB, Buerke B, Kuemmel A, Thrull M, Wiewrodt R, Baumgartner H, Berdel WE, Mohr M.

PLoS One. 2016 May 12;11(5):e0155398. doi: 10.1371/journal.pone.0155398. eCollection 2016.

PMID: 27171441 Free PMC article.

26. Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC.

Schmidt LH, Kuemmel A, Schliemann C, Schulze A, Humberg J, Mohr M, Görlich D, Hartmann W, Bröckling S, Marra A, Hillejan L, Goletz S, Karsten U, Berdel WE, Spieker T, Wiewrodt R.

Lung Cancer. 2016 Feb;92:8-14. doi: 10.1016/j.lungcan.2015.11.019. Epub 2015 Nov 27.

PMID: 26775589

27. Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.

Heigener DF, Schumann C, Sebastian M, Sadjadian P, Stehle I, Märten A, Lüers A, Griesinger F, Scheffler M; Afatinib Compassionate Use Consortium (ACUC).

Oncologist. 2015 Oct;20(10):1167-74. doi: 10.1634/theoncologist.2015-0073. Epub 2015 Sep 9.

PMID: 26354527 Free PMC article.

28. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.

Schmidt LH, Kümmel A, Görlich D, Mohr M, Bröckling S, Mikesch JH, Grünewald I, Marra A, Schultheis AM, Wardelmann E, Müller-Tidow C, Spieker T, Schliemann C, Berdel WE, Wiewrodt R, Hartmann W.

PLoS One. 2015 Aug 27;10(8):e0136023. doi: 10.1371/journal.pone.0136023. eCollection 2015.

PMID: 26313362 Free PMC article.

29. Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.

Hoffknecht P, Tufman A, Wehler T, Pelzer T, Wiewrodt R, Schütz M, Serke M, Stöhlmacher-Williams J, Märten A, Maria Huber R, Dickgreber NJ; Afatinib Compassionate Use Consortium (ACUC).

J Thorac Oncol. 2015 Jan;10(1):156-63. doi: 10.1097/JTO.0000000000000380.

PMID: 25247337 Free PMC article.

30. Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

Schuler M, Fischer JR, Grohé C, Gütz S, Thomas M, Kimmich M, Schneider CP, Laack E, Märten A; Afatinib Compassionate Use Consortium.

Oncologist. 2014 Oct;19(10):1100-9. doi: 10.1634/theoncologist.2014-0103. Epub 2014 Sep 17.

PMID: 25232040 Free PMC article.

31. Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.

Schmidt LH, Görlich D, Spieker T, Rohde C, Schuler M, Mohr M, Humberg J, Sauer T, Thoenissen NH, Huge A, Voss R, Marra A, Faldum A, Müller-Tidow C, Berdel WE, Wiewrodt R.

J Thorac Oncol. 2014 Sep;9(9):1294-304. doi: 10.1097/JTO.0000000000000243.

PMID: 25036876

32. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis.

Mohr M, Schliemann C, Biermann C, Schmidt LH, Kessler T, Schmidt J, Wiebe K, Müller KM, Hoffmann TK, Groll AH, Werner C, Kessler C, Wiewrodt R, Rudack C, Berdel WE.

Oncol Lett. 2014 Nov;8(5):1912-1918. doi: 10.3892/ol.2014.2486. Epub 2014 Aug 28.

PMID: 25289079 Free PMC article.

33. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.

Mikesch JH, Kuhlmann M, Demant A, Krug U, Thoennissen GB, Schmidt E, Kessler T, Schliemann C, Pohlen M, Mohr M, Evers G, Köhler G, Wessling J, Mesters R, Müller-Tidow C, Berdel WE, Thoennissen NH.

Ann Hematol. 2013 Aug;92(8):1041-8. doi: 10.1007/s00277-013-1738-9. Epub 2013 Mar 27.

PMID: 23532626

34. Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsis.

Razlaf P, Pabst D, Mohr M, Kessler T, Wiewrodt R, Stelljes M, Reinecke H, Waltenberger J, Berdel WE, Lebiedz P.

Respir Med. 2012 Nov;106(11):1509-16. doi: 10.1016/j.rmed.2012.08.007. Epub 2012 Sep 1.

PMID: 22944604

35. High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases.

Mohr M, Hartig I, Kessler T, Hamisch C, Kliesch S, Krug U, Spieker T, Semik M, Wiebe K, Pühse G, Hertle L, Liersch R, Müller-Tidow C, Mesters RM, Berdel WE.

Bone Marrow Transplant. 2012 Oct;47(10):1321-5. doi: 10.1038/bmt.2012.14. Epub 2012 Feb 13.

PMID: 22327130 Clinical Trial.

36. [Thoracic oncology].

Schmidt LH, Mohr M, Wiewrodt R.

Dtsch Med Wochenschr. 2011 Oct;136(40):2029-32. doi: 10.1055/s-0031-1286387. Epub 2011 Sep 28.

PMID: 21960333 Review. German. No abstract available.

37. Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients.

Brunnberg U, Mohr M, Noppeney R, Dürk HA, Sauerland MC, Müller-Tidow C, Krug U, Koschmieder S, Kessler T, Mesters RM, Schulz C, Kosch M, Büchner T, Ehninger G, Dührsen U, Serve H, Berdel WE.

Ann Oncol. 2012 Apr;23(4):990-6. doi: 10.1093/annonc/mdr346. Epub 2011 Aug 2.

PMID: 21810729 Clinical Trial.

38. Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade.

Mohr M, Jacobi AM.

Scand J Rheumatol. 2011;40(5):400-1. doi: 10.3109/03009742.2011.599072.

PMID: 21961704 No abstract available.

39. Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.

Kessler T, Mohr M, Müller-Tidow C, Krug U, Brunnberg U, Mohr B, Schliemann C, Sauerland C, Serve H, Büchner T, Berdel WE, Mesters RM.

Leuk Res. 2008 Mar;32(3):491-4. doi: 10.1016/j.leukres.2007.06.015. Epub 2007 Aug 1.

PMID: 17675230 Clinical Trial.

40. Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.

Oelmann E, Thomas M, Serve H, Kienast J, Zühlsdorf M, Mohr M, Klinke F, Dölken G, Macha H, Schmidt EW, Berdel WE.

Oncology. 2002;63(3):248-53. doi: 10.1159/000065473.

PMID: 12381904 Clinical Trial.

41. Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia.

Seeliger S, Baumann M, Mohr M, Jürgens H, Frosch M, Vormoor J.

Eur J Pediatr. 2001 Aug;160(8):492-6. doi: 10.1007/s004310100778.

PMID: 11548187

42.  Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).

Cassens U, Momkvist PH, Zuehlsdorf M, Mohr M, Kienast J, Berdel WE, Sibrowski W.

Bone Marrow Transplant. 2001 Jul;28(1):13-20. doi: 10.1038/sj.bmt.1703082.

PMID: 11498739 Clinical Trial.

43.  Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.

Mohr M, Dalmis F, Hilgenfeld E, Oelmann E, Zühlsdorf M, Kratz-Albers K, Nolte A, Schmitmann C, Onaldi-Mohr D, Cassens U, Serve H, Sibrowski W, Kienast J, Berdel WE.

Clin Cancer Res. 2001 Jan;7(1):51-7.

PMID: 11205918